Pharma Reviews: Natco Pharma receives EIR from USFDA, stock up 1.05 percent

NEW DELHI: Drug firm Natco Pharma today said it has received establishment inspection report (EIR) from the US health regulator for its Kothur facility ...
Read more: Natco Pharma receives EIR from USFDA, stock up 1.05 percent